◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
BMY
BMY
(BMY)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
PR Newswire
·
vor 1 Std.
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Bloomberg
·
vor 2 Std.
Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million
Zacks
·
vor 22 Std.
Can BMY's CELMoD Program Advancements Strengthen Its Oncology Portfolio?
MT Newswires
·
vor 23 Std.
Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers
Business Wire
·
vor 1 Tagen
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Motley Fool
·
vor 1 Tagen
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Frag BlackSpecter AI über BMY
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist BMY kaufenswert?
BMY Earnings Analyse
BMY Bewertung
AI Chat öffnen →